Stock listing
NASDAQ:PATH NuPathe Inc. Stock
Follow NuPathe Inc. into a list and get an email when it puts out news.
Last close · NASDAQ:PATH
$4.25 USD
Close on Feb 21, 2014 · No longer trades
- Lowest – highest close
- $1.60 – $9.61 USDSince Aug 6, 2010 · lowest Dec 21, 2011 · highest Aug 6, 2010
Delisted NASDAQ:PATH no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:PATH
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
NuPathe Inc. on 6ix
- Decks
- 6 decks · latest Sep 11, 2013
Events
- Next results
- Dec 3, 2026 (expected)
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Jul 31, 2026 | Sep 3, 2026 · After close | −16.6% |
| Quarter to Apr 30, 2026 | May 28, 2026 · After close | +1.2% |
| Quarter to Jan 31, 2026 | Mar 11, 2026 · After close | −8.2% |
| Quarter to Oct 31, 2025 | Dec 3, 2025 · After close | +24.4% |
| Quarter to Jul 31, 2025 | Sep 4, 2025 · After close | +5.9% |
| Quarter to Apr 30, 2025 | May 29, 2025 · After close | +2.9% |
| Quarter to Jan 31, 2025 | Mar 12, 2025 · After close | −15.7% |
| Quarter to Oct 31, 2024 | Dec 5, 2024 · After close | −0.9% |
| Quarter to Jul 31, 2024 | Sep 5, 2024 · After close | −6.0% |
| Quarter to Apr 30, 2024 | May 29, 2024 · After close | −34.0% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Jan 31, 2024 | Mar 13, 2024 · After close | −6.9% |
| Quarter to Oct 31, 2023 | Nov 30, 2023 · After close | +26.7% |
| Quarter to Jul 31, 2023 | Sep 5, 2023 · After close | +0.3% |
| Quarter to Apr 30, 2023 | May 24, 2023 · After close | −11.2% |
| Quarter to Jan 31, 2023 | Mar 15, 2023 · After close | +17.6% |
| Quarter to Oct 31, 2022 | Dec 1, 2022 · After close | +12.5% |
| Quarter to Jul 31, 2022 | Sep 6, 2022 · After close | −11.2% |
| Quarter to Apr 30, 2022 | Jun 1, 2022 · After close | +16.7% |
| Quarter to Jan 31, 2022 | Mar 30, 2022 · After close | −25.6% |
| Quarter to Oct 31, 2021 | Dec 8, 2021 · After close | −1.4% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2013) | Investor deck | 32 slides | Sep 11, 2013 |
| Investor Presentation (November 2012) | Investor deck | 20 slides | Nov 13, 2012 |
| Investor Presentation (October 2012) | Investor deck | 19 slides | Oct 9, 2012 |
| Investor Presentation (October 2011) | Investor deck | 21 slides | Oct 3, 2011 |
| JP Morgan Healthcare Conference January 2011 | Conference | 21 slides | Jan 10, 2011 |
| Stifel Nicolaus 2010 Healthcare Conference | Conference | 21 slides | Sep 16, 2010 |
Cap table
Built by 6ix from NuPathe Inc.’s releases
- Common shares
- 456,464,703
- Fully diluted
- 456,464,703
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 456,464,703 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 456,464,703 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Armando Anido Other companies: Scynexis, Inc. (Director · Since at least Jan 21, 2019); Vaxart, Inc. (Director · Sep 21, 2015 – May 18, 2017 · Past); Zynerba Pharmaceuticals Inc (Chairman & Chief Exec. Officer, Director · Aug 4, 2015 – Oct 10, 2023 · Past); Adolor Corp (Director · May 18, 2010 – Dec 7, 2011 · Past); Auxilium Pharmaceuticals Inc (CEO & President, Director · Apr 12, 2010 – Oct 7, 2011 · Past) | Chief Executive Officer, Director · Jul 25, 2012 – Feb 21, 2014 · Past |
| Michael Cola Other companies: Phathom Pharmaceuticals, Inc. (Director · Since at least Oct 24, 2019); Sage Therapeutics Inc (Director · Since at least Sep 11, 2014); Avalo Therapeutics, Inc. (Chief Executive Officer, Director · Feb 3, 2020 – Oct 1, 2021 · Past); Aevi Genomic Medicine LLC (Chief Executive Officer, Director · Sep 13, 2013 – Jun 9, 2020 · Past); Vanda Pharmaceuticals Inc. (Director · Jun 14, 2012 – Jun 13, 2019 · Past) | Director · Sep 30, 2011 – Feb 21, 2014 · Past |
Log in to ask 6ix AI your own questions about NuPathe Inc.